Different mechanisms of spinal fusion using equine bone protein extract, rhBMP-2 and autograft during the process of anterior lumbar interbody fusion

Biomaterials

Volumn 30, Issue 6, 2009, Pages 991-1004

  Zou, Xuenong ^a,b   Zou, Lijin ^b,c   Foldager, Casper ^b   Bendtsen, Michael ^b   Feng, Wenzhou ^a   Bünger, Cody E ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NANCHANG UNIVERSITY   (China)

Author keywords

BMP (bone morphogenetic protein); Bone graft; Equine bone protein extract; Gene expression; GeneChip

Indexed keywords

BIOACTIVITY; BIOLOGICAL MATERIALS; CARTILAGE; CONFORMAL MAPPING; GENE EXPRESSION; GRAFTING (CHEMICAL); PROTEINS; SELF ORGANIZING MAPS;

BIOLOGICAL PROCESSES; BMP (BONE MORPHOGENETIC PROTEIN); BONE GRAFT; CHEMOKINES; DATA ANALYSIS; DIFFERENT MECHANISMS; ENDOCHONDRAL OSSIFICATIONS; EQUINE BONE PROTEIN EXTRACT; EXPRESSION PATTERNS; EXPRESSION PROFILES; GENECHIP; GRAFT MATERIALS; HIERARCHICAL CLUSTERING; INTERMEDIATE PHASIS; LUMBAR INTERBODY FUSIONS; MICROARRAY TECHNOLOGIES; MOLECULAR MECHANISMS; OSTEOBLASTIC DIFFERENTIATIONS; PORCINE MODELS; PROGENITOR CELLS; RHBMP-2; SPINAL FUSIONS; UP REGULATIONS;

BONE;

BONE MORPHOGENETIC PROTEIN 2; CHEMOKINE; PROSTAGLANDIN SYNTHASE; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; BONE GRAFT; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENCHONDRAL OSSIFICATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HORSE; MICROARRAY ANALYSIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINE FUSION; STEM CELL; SWINE; UPREGULATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORSES; HUMANS; LUMBAR VERTEBRAE; METABOLIC NETWORKS AND PATHWAYS; RECOMBINANT PROTEINS; SPINAL FUSION; SUS SCROFA; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EQUIDAE; SUS;

EID: 57749199071     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.10.061     Document Type: Article

References (59)

1. Summers B.N., and Eisenstein S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71 (1989) 677-680
2. Banwart J.C., Asher M.A., and Hassanein R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 20 (1995) 1055-1060
3. Burkus J.K., Gornet M.F., Dickman C., and Zdeblick T.A. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15 (2002) 337-349
4. Burkus J.K., Heim S.E., Gornet M.F., and Zdeblick T.A. Is INFUSE Bone Graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech 16 (2003) 113-122
5. Burkus J.K., Sandhu H.S., Gornet M.F., and Longley M.C. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87 (2005) 1205-1212
6. Haid Jr. R.W., Branch Jr. C.L., Alexander J.T., and Burkus J.K. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4 (2004) 527-538 [discussion 538-9]
7. Mummaneni P.V., Pan J., Haid R.W., and Rodts G.E. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg Spine 1 (2004) 19-23
8. McKay W.F., Peckham S.M., and Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31 (2007) 729-734
9. Boakye M., Mummaneni P.V., Garrett M., Rodts G., and Haid R. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2 (2005) 521-525
10. Vaidya R., Carp J., Sethi A., Bartol S., Craig J., and Les C.M. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16 (2007) 1257-1265
11. Buttermann G.R. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J 8 (2008) 426-435
12. van der Zande M, Springer M, Krause A, Poulsen K, Jesen ON, Walboomers XF, et al. Anaylsis of the osteoinductive materials COLLOSS and COLLOSS E. In: European Conference on Biomaterials. Nantes, France; 2006.
13. El-Sabban M.E., El-Khoury H., Hamdan-Khalil R., Sindet-Pedersen S., and Bazarbachi A. Xenogenic bone matrix extracts induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Regen Med 2 (2007) 383-390
14. Li H., Springer M., Zou X., Briest A., and Bünger C. Ectopic bone induction by equine bone protein extract. Adv Exp Med Biol 585 (2006) 393-402
15. Huffer W.E., Benedict J.J., Rettenmaier R., and Briest A. Osteoinduction with COLLOSS, COLLOSS E, and GFm. Adv Exp Med Biol 585 (2006) 87-100
16. Nienhuijs M.E., Walboomers X.F., Merkx M.A., Stoelinga P.J., and Jansen J.A. Bone-like tissue formation using an equine COLLOSS E-filled titanium scaffolding material. Biomaterials 27 (2006) 3109-3114
17. Li H., Zou X., Springer M., Briest A., Lind M., and Bünger C. Instrumented anterior lumbar interbody fusion with equine bone protein extract. Spine 32 (2007) E126-E129
18. Huffer W.E., Benedict J.J., Turner A.S., Briest A., Rettenmaier R., Springer M., et al. Repair of sheep long bone cortical defects filled with COLLOSS, COLLOSS E, OSSAPLAST, and fresh iliac crest autograft. J Biomed Mater Res B Appl Biomater 82 (2007) 460-470
19. Yasko A.W., Lane J.M., Fellinger E.J., Rosen V., Wozney J.M., and Wang E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 74 (1992) 659-670
20. Minamide A., Tamaki T., Kawakami M., Hashizume H., Yoshida M., and Sakata R. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 24 (1999) 1863-1870 [discussion 1871-72]
21. Vehof J.W., Takita H., Kuboki Y., Spauwen P.H., and Jansen J.A. Histological characterization of the early stages of bone morphogenetic protein-induced osteogenesis. J Biomed Mater Res 61 (2002) 440-449
22. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87 (1990) 2220-2224
23. King G.N., King N., Cruchley A.T., Wozney J.M., and Hughes F.J. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 76 (1997) 1460-1470
24. Ebara S., and Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27 (2002) S10-S15
25. Carstens M.H., Chin M., and Li X.J. In situ osteogenesis: regeneration of 10-cm mandibular defect in porcine model using recombinant human bone morphogenetic protein-2 (rhBMP-2) and Helistat absorbable collagen sponge. J Craniofac Surg 16 (2005) 1033-1042
26. Foldager C., Bendtsen M., Zou X., Zou L., Olsen A.K., Munk O.L., et al. PET/CT and MRI for monitoring interbody fusion using equine bone protein extract, rhBMP-2 and autograft. Spine 33 (2008) 2683-2690
27. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94 (2002) 513-521
28. Ge X., Yamamoto S., Tsutsumi S., Midorikawa Y., Ihara S., Wang S.M., et al. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86 (2005) 127-141
29. Tsai S., Cassady J.P., Freking B.A., Nonneman D.J., Rohrer G.A., and Piedrahita J.A. Annotation of the Affymetrix porcine genome microarray. Anim Genet 37 (2006) 423-424
30. Lecanda F., Warlow P.M., Sheikh S., Furlan F., Steinberg T.H., and Civitelli R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151 (2000) 931-944
31. Ilvesaro J., Vaananen K., and Tuukkanen J. Bone-resorbing osteoclasts contain gap-junctional connexin-43. J Bone Miner Res 15 (2000) 919-926
32. Herde K., Hartmann S., Brehm R., Kilian O., Heiss C., Hild A., et al. Connexin 43 expression of foreign body giant cells after implantation of nanoparticulate hydroxyapatite. Biomaterials 28 33 (2007) 4912-4921
33. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., and Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8 (2007) 51
34. Luo X.H., Guo L.J., Xie H., Yuan L.Q., Wu X.P., Zhou H.D., et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21 (2006) 1648-1656
35. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109 (2002) 1405-1415
36. Glassman S.D., Rose S.M., Dimar J.R., Puno R.M., Campbell M.J., and Johnson J.R. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 23 (1998) 834-838
37. Chikazu D., Li X., Kawaguchi H., Sakuma Y., Voznesensky O.S., Adams D.J., et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17 (2002) 1430-1440
38. Fisher M.C., Meyer C., Garber G., and Dealy C.N. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 37 (2005) 741-750
39. Hassager C., Fitzpatrick L.A., Spencer E.M., Riggs B.L., and Conover C.A. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J Clin Endocrinol Metab 75 (1992) 228-233
40. Conover C.A., and Khosla S. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Growth Horm IGF Res 13 (2003) 328-335
41. Palermo C., Manduca P., Gazzerro E., Foppiani L., Segat D., and Barreca A. Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab 286 (2004) E648-E657
42. Conover C.A., Johnstone E.W., Turner R.T., Evans G.L., John Ballard F.J., Doran P.M., et al. Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12 (2002) 178-183
43. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 (2003) 2779-2791
44. Kubota S., and Takigawa M. Role of CCN2/CTGF/Hcs24 in bone growth. Int Rev Cytol 257 (2007) 1-41
45. Takita H., Kikuchi M., Sato Y., and Kuboki Y. Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate). Connect Tissue Res 43 (2002) 520-523
46. Barone L.M., Owen T.A., Tassinari M.S., Bortell R., Stein G.S., and Lian J.B. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J Cell Biochem 46 (1991) 351-365
47. Newman B., Gigout L.I., Sudre L., Grant M.E., and Wallis G.A. Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol 154 (2001) 659-666
48. Shen G. The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage. Orthod Craniofac Res 8 (2005) 11-17
49. Haze A., Taylor A.L., Blumenfeld A., Rosenfeld E., Leiser Y., Dafni L., et al. Amelogenin expression in long bone and cartilage cells and in bone marrow progenitor cells. Anat Rec (Hoboken) 290 (2007) 455-460
50. Probst A., and Spiegel H.U. Cellular mechanisms of bone repair. J Invest Surg 10 (1997) 77-86
51. Szczesny G., Olszewski W.L., Gewartowska M., Zaleska M., and Górecki A. The healing of tibial fracture and response of the local lymphatic system. J Trauma 63 (2007) 849-854
52. Posner L.J., Miligkos T., Gilles J.A., Carnes D.L., Taddeo D.R., and Graves D.T. Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone 21 (1997) 321-327
53. Kim M.S., Day C.J., Selinger C.I., Magno C.L., Stephens S.R., and Morrison N.A. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 281 (2006) 1274-1285
54. Liu Y.Z., Dvornyk V., Lu Y., Shen H., Lappe J.M., Recker R.R., et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 280 (2005) 29011-29016
55. Lundberg P., Koskinen C., Baldock P.A., Löthgren H., Stenberg A., Lerner U.H., et al. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Biochem Biophys Res Commun 352 (2007) 444-448
56. Hatori K., Sasano Y., Takahashi I., Kamakura S., Kagayama M., and Sasaki K. Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation. Anat Rec A Discov Mol Cell Evol Biol 277 (2004) 262-271
57. Zhu W., Boachie-Adjei O., Rawlins B.A., Frenkel B., Boskey A.L., Ivashkiv L.B., et al. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem 282 (2007) 18676-18685
58. Zachos T.A., Shields K.M., and Bertone A.L. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. J Orthop Res 24 (2006) 1279-1291
59. Jones C.B. Biological basis of fracture healing. J Orthop Trauma 19 (2005) S1-S3